Urethra Transitional Cell Carcinoma, also known as urethral transitional cell carcinoma, is related to bladder cancer and transitional cell carcinoma. An important gene associated with Urethra Transitional Cell Carcinoma is UPK3A (Uroplakin 3A), and among its related pathways/superpathways are ERK Signaling and MIF Mediated Glucocorticoid Regulation. The drugs Bevacizumab and Avelumab have been mentioned in the context of this disorder. Affiliated tissues include prostate and endothelial, and related phenotypes are Decreased viability and Increased human cytomegalovirus (HCMV) strain AD169 replication